ProductNum | picture | CAS No. | Name and description | Size | Formula | Quick order |
---|---|---|---|---|---|---|
GC11169-5mg |
|
328087-38-3 |
Phortress
|
0 | C20H23FN4OS.2HCl | |
GC11168-1g |
|
926927-61-9 |
Motolimod (VTX-2337)
|
0 | C28H34N4O2 | |
GC11168-500mg |
|
926927-61-9 |
Motolimod (VTX-2337)
|
0 | C28H34N4O2 | |
GC11168-10mM (in 1mL DMSO) |
|
926927-61-9 |
Motolimod (VTX-2337)
|
0 | C28H34N4O2 | |
GC11168-25mg |
|
926927-61-9 |
Motolimod (VTX-2337)
|
0 | C28H34N4O2 | |
GC11168-5mg |
|
926927-61-9 |
Motolimod (VTX-2337)
|
0 | C28H34N4O2 | |
GC11167-50mg |
|
852391-19-6 |
Necrostatin 2
|
0 | C13H12ClN3O2 | |
GC11167-25mg |
|
852391-19-6 |
Necrostatin 2
|
0 | C13H12ClN3O2 | |
GC11167-10mg |
|
852391-19-6 |
Necrostatin 2
|
0 | C13H12ClN3O2 | |
GC11167-5mg |
|
852391-19-6 |
Necrostatin 2
|
0 | C13H12ClN3O2 | |
GC11166-10mM (in 1mL DMSO) |
|
122852-69-1 |
Alosetron Hydrochloride
|
0 | C17H19ClN4O | |
GC11166-50mg |
|
122852-69-1 |
Alosetron Hydrochloride
|
0 | C17H19ClN4O | |
GC11166-10mg |
|
122852-69-1 |
Alosetron Hydrochloride
|
0 | C17H19ClN4O | |
GC11165-50mg |
|
371935-74-9 |
PI-103
|
0 | C19H16N4O3 | |
GC11165-10mM (in 1mL DMSO) |
|
371935-74-9 |
PI-103
|
0 | C19H16N4O3 | |
GC11165-100mg |
|
371935-74-9 |
PI-103
|
0 | C19H16N4O3 | |
GC11165-10mg |
|
371935-74-9 |
PI-103
|
0 | C19H16N4O3 | |
GC11165-5mg |
|
371935-74-9 |
PI-103
|
0 | C19H16N4O3 | |
GC11163-100mg |
|
— |
L-NMMA (citrate)
|
0 | 3[C7H16N4O2] · C6H8O7 | |
GC11163-50mg |
|
— |
L-NMMA (citrate)
|
0 | 3[C7H16N4O2] · C6H8O7 | |